Literature DB >> 1804678

Tuberculosis elimination in the countries of Europe and other industrialized countries.

L Clancy1, H L Rieder, D A Enarson, S Spinaci.   

Abstract

The working group summarized the conclusions of the workshop with the intention of providing a guide for the preparation of national plans for tuberculosis elimination. The basic strategies that appear consistently effective are: 1. Direct government responsibility for diagnosis, treatment and prevention of tuberculosis (the government is responsible by law for assuring that tuberculosis is identified early, and that cure of the patients is achieved). 2. Maintenance (or development) of properly designed disease surveillance and a programme monitoring system. 3. Availability of specialized tuberculosis personnel at regional and provincial level, responsible for close monitoring of the diagnostic skills and patient prioritization in general health institutions. Regarding research it was felt that no immediate practical applications of new techniques in the diagnosis of mycobacterial diseases, in treatment, or in vaccination can be recommended, but that further basic research in the field of mycobacteria should be pursued and supported.

Entities:  

Mesh:

Year:  1991        PMID: 1804678

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  18 in total

1.  Impact of immigration and HIV infection on tuberculosis incidence in an area of low tuberculosis prevalence.

Authors:  I Baussano; M Bugiani; D Gregori; C Pasqualini; V Demicheli; F Merletti
Journal:  Epidemiol Infect       Date:  2006-04-20       Impact factor: 2.451

2.  Cost-effectiveness analysis of tuberculosis control policies in Ivanovo Oblast, Russian Federation. Ivanovo Tuberculosis Project Study Group.

Authors:  G B Migliori; A G Khomenko; V V Punga; M Ambrosetti; I Danilova; L N Ribka; M Grzemska; H Sawert; M C Raviglione
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408

3.  Survey of BCG vaccination policy in Europe: 1994-96.

Authors:  L Trnka; D Dankova; J Zitova; L Cimprichova; G B Migliori; L Clancy; J P Zellweger
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408

4.  Policy Implications of Mathematical Modeling of Latent Tuberculosis Infection Testing and Treatment Strategies to Accelerate Tuberculosis Elimination.

Authors:  Suzanne M Marks; David W Dowdy; Nicolas A Menzies; Priya B Shete; Joshua A Salomon; Andrea Parriott; Sourya Shrestha; Jennifer Flood; Andrew N Hill
Journal:  Public Health Rep       Date:  2020 Jul/Aug       Impact factor: 2.792

5.  Inhaled Corticosteroids And Risk Of Tuberculosis In Patients With Obstructive Lung Diseases: A Systematic Review And Meta-Analysis Of Non-randomized Studies.

Authors:  Giorgio Castellana; Marco Castellana; Carlo Castellana; Giuseppe Castellana; Emanuela Resta; Mauro Carone; Onofrio Resta
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-09-26

6.  Prevalence and risk factors for transmission of infection among children in household contact with adults having pulmonary tuberculosis.

Authors:  M Singh; M L Mynak; L Kumar; J L Mathew; S K Jindal
Journal:  Arch Dis Child       Date:  2005-06       Impact factor: 3.791

7.  Tuberculosis incidence among contacts of active pulmonary tuberculosis.

Authors:  M Cailleaux-Cezar; D de A Melo; G M Xavier; C L G de Salles; F C Q de Mello; A Ruffino-Netto; J E Golub; A Efron; R E Chaisson; M B Conde
Journal:  Int J Tuberc Lung Dis       Date:  2009-02       Impact factor: 2.373

8.  Secular trends of tuberculosis in western Europe.

Authors:  M C Raviglione; P Sudre; H L Rieder; S Spinaci; A Kochi
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

Review 9.  The new diagnostic mycobacteriology laboratory.

Authors:  M Salfinger; G E Pfyffer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

10.  Persistent high incidence of tuberculosis in immigrants in a low-incidence country.

Authors:  Troels Lillebaek; Ase B Andersen; Asger Dirksen; Else Smith; Lene T Skovgaard; Axel Kok-Jensen
Journal:  Emerg Infect Dis       Date:  2002-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.